@FiercePharma: Phibro records strong sales growth despite industry shift from antibiotics. FierceAnimalHealth story | Follow @FiercePharma
@EricPFierce: Alexion expanding in Ireland. Will spend $506M on its first biologics plant outside of U.S. News from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: Endo plots a relaunch of Auxilium's ED med, complete with new salesforce and DTC. FiercePharmaMarketing report | Follow @CarlyHFierce
> An Irish court has awarded a former Novartis ($NVS) employee €40,000 for unfair dismissal. More
> A couple is alleging that Pfizer ($PFE) unit Wyeth has for 30 years concealed the risk of serious allergic reactions to pain reliever Advil, claiming in a New York court that the drug melted off 80% of their daughter's skin. Report (sub. req.)
> The FDA has issued a complete response letter in response to Johnson & Johnson's ($JNJ) sNDA for the long-acting version of antipsychotic Invega Sustenna. More
> Biogen ($BIIB) has named Matt Griffiths as its Chief Information Officer. Release
Medical Device News
@FierceMedDev: FDA approves Roche's cancer diagnostic as a guide to use of Amgen, Lilly meds. FierceDiagnostics story | Follow @FierceMedDev
@VarunSaxena2: Lilly hopes new drug delivery R&D center will prove useful in osteoporosis, diabetes arenas. FierceDrugDelivery article | Follow @VarunSaxena2
@EmilyWFierce: ICYMI from FiercePharma: Biogen's hot MS meds could push Pfizer off its CNS throne. Report | Follow @EmilyWFierce
> Glaucoma micro stent player Glaukos files to raise up to $86M in an IPO. Story
> Seattle hospital sues Olympus over duodenoscope devices tied to superbug outbreak. Article
Biotech News
@FierceBiotech: China's BeiGene banks $97M to get its cancer drugs into the clinic. Article | Follow @FierceBiotech
@JohnCFierce: No, the IPO flood won't float all boats. Gelesis scraps plans, for now, for a $52M IPO. More | Follow @JohnCFierce
> One of Takeda's big cancer bets flops in a Phase III lymphoma trial. Report
> Sanofi doubles down on Selecta collaboration, adding $300M in fresh incentives. Article
Pharma Marketing News
> Wrongfully fired rep needs a real job offer, judge tells Bayer. And fork over that back pay, stat. More
> Want to know a secret? Pharma's patient services are going to waste. News
> Can pharma + tech wearables be a match made in patient heaven? Report
> Lucky 7 diabetes meds to join blockbuster club by 2020. Story
> Endo plots a relaunch of Auxilium's ED med, complete with new salesforce and DTC. More
Biotech Research News
> Moderna tops CNBC's list of most disruptive new technologies. Item
> VCU scientist preps gene therapy/drug combo for PhI prostate cancer study. Story
> Garvan team spotlights role of rogue cells in autoimmune diseases. Article
> Swift setback: A preclinical success in hep B is followed by safety woes. News
> Biopharma companies jump into the big data stampede for genetic triggers of disease. Report
Diagnostics News
> Soon-Shiong reels in $100M for cancer genomics unit. Item
> FDA approves Roche's cancer diagnostic as a guide to use of Amgen, Lilly meds. Story
> Navidea scores $60M loan to broaden reach for Lymphoseek. Article
> HTG Molecular Diagnostics unveils $50M IPO for genomic profiling technology. More
> Adaptive Biotechnologies reels in $195M for immunosequencing tech. News
And Finally... Breast feeding may cut the risk of breast-cancer recurrence, a new study shows. More (sub. req.)